Cure My Disease

Don't miss your cure!

 Log in / Sign up

Predictive value of lung ultrasound combined with serum ANGPL4 levels for NICU admission needs in late preterm and term neonates with respiratory distress in the transion period

NCT ID NCT07809971

NEW Sponsor: Tanta University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 09, 2026

Summary

The aim of this study is to evaluate the validity of point-of-care lung ultrasound (POC-LUS) and serum ANGPL4 levels for predicting NICU admission needs in late preterm and full-term neonates with respiratory distress shortly after birth in the transition period.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

80 people

The number who actually took part.

Started

Aug 2025

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

80 late preterm and term neonates with clinical evidence of respiratory distress soon after birth, at the NICU, Pediatrics Department, Tanta University Hospitals

Ages

Up to 2 hours

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

This study will include 80 late preterm and term neonates (≥34 gestional weeks) who will show any clinical signs of respiratory distress in the delivery room or within 30 minutes after birth. The exclusion criteria: 1. Preterm neonates with gestional age \<34 weeks. 2. Neonates with antenatal diagnosis of congenital anomalies of the lungs or thoracic cage. 3. Neonates with antenatal diagnosis of congenital heart disease. 4. Neonates with antenatal diagnosis of other major congenital anomalies or chromsomal abnormality. 5. Neonates born with severe perinatal asphyxia. 6. Neonates born with severe apnea requiring intubation in the delitery room.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung ultrasound score are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

newborn respiratory distress syndrome Pulmonary Atelectasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung ultrasound score Neonatal respiratory distress

Contacts and locations

Locations

  • faculty of medicine,Tanta University

    Tanta, Q2x2+cp Tanta 2, Egypt, 31527, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.